Panacea Index Logo

Command Palette

Search for a command to run...

A low-fat high-carbohydrate diet reduces plasma total adiponectin concentrations compared to a moderate-fat diet with no impact on biomarkers of systemic inflammation in a randomized controlled feeding study.

European journal of nutrition
February 1, 2016
Xiaoling Song et al. (7 authors)
Journal ArticleRandomized Controlled TrialResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to compare the effects of a high-carbohydrate diet versus a moderate-fat diet on biomarkers of systemic inflammation and adiponectin levels in relatively healthy adults.

Results Summary

The study found that a high-carbohydrate diet had little impact on systemic inflammation markers but reduced adiponectin concentrations compared to a moderate-fat diet. Weight loss modestly increased adiponectin but did not significantly affect other inflammatory biomarkers.

Population

Relatively healthy adults aged 21-76 years with BMIs ranging from 19.2 to 35.5 kg/m².

Effective Dosage

Not specified (eucaloric low-fat high-carbohydrate diet: 18% protein, 18% fat, 64% carbohydrate).

Duration

6 weeks

Interactions

None mentioned

Extracted Claims (11)
InterventionDirectionEndpointPopulationDosageImpactClaim #
eucaloric moderate-fat diet (18% protein, 36% fat, and 46% carbohydrate)
no change
plasma C-reactive protein (CRP), interleukin-6 (IL-6), soluble tumor necrosis factor receptors I and II (sTNFRI and II), and adiponectin
102 participants (age 21-76 years and BMI 19.2-35.5 kg/m(2))
no significant change
none of the endpoints were differentially affected
#1
eucaloric low-fat high-carbohydrate diet (18% protein, 18% fat, and 64% carbohydrate)
no change
plasma C-reactive protein (CRP), interleukin-6 (IL-6), soluble tumor necrosis factor receptors I and II (sTNFRI and II), and adiponectin
102 participants (age 21-76 years and BMI 19.2-35.5 kg/m(2))
no significant change
none of the endpoints were differentially affected
#2
low-calorie (33% reduced) low-fat high-carbohydrate diet
decrease
body weight and fat mass
participants consuming the low-calorie low-fat diet
-
significantly greater reductions
#3
low-calorie (33% reduced) low-fat high-carbohydrate diet
no change
plasma C-reactive protein (CRP), interleukin-6 (IL-6), soluble tumor necrosis factor receptors I and II (sTNFRI and II), and adiponectin
102 participants (age 21-76 years and BMI 19.2-35.5 kg/m(2))
no significant change
none of the endpoints were differentially affected
#4
weight loss
increase
adiponectin
-
-
tended to be increased
#5
low-fat diets
decrease
adiponectin
groups consuming the low-fat diets
-
was reduced
#6
intervention diets or weight loss
no change
CRP, IL-6, or sTNFRI and II
-
no effect
No effect
#7
moderate weight loss
no change
systemic inflammation
relatively healthy adults
minimal effects
had minimal effects
#8
moderate weight loss
increase
plasma adiponectin
relatively healthy adults
only modestly
raised
#9
lower dietary fat and higher carbohydrate content
no change
measures of systemic inflammation
-
little impact
had little impact
#10
lower dietary fat and higher carbohydrate content
decrease
adiponectin concentrations
-
-
reduced
#11
Abstract

PURPOSE: We compared the effects of a eucaloric moderate-fat diet (18% protein, 36% fat, and 46% carbohydrate), a eucaloric low-fat high-carbohydrate diet (18% protein, 18% fat, and 64% carbohydrate), and a low-calorie (33% reduced) low-fat high-carbohydrate diet on biomarkers of systemic inflammation. METHODS: We randomly assigned 102 participants (age 21-76 years and BMI 19.2-35.5 kg/m(2)) to the three different diets for 6 weeks in a parallel design intervention trial. All foods were provided. Ninety-three participants completed all study procedures; 92 were included in the analyses. Endpoints included plasma C-reactive protein (CRP), interleukin-6 (IL-6), soluble tumor necrosis factor receptors I and II (sTNFRI and II), and adiponectin. RESULTS: In the unadjusted primary analyses, none of the endpoints were differentially affected by the dietary interventions despite the significantly greater reductions in body weight and fat mass in participants consuming the low-calorie low-fat diet compared to the eucaloric diets (p < 0.001). When including weight change in the model in secondary analysis, adiponectin tended to be increased with weight loss (time × weight change interaction, p = 0.051). Adjusted for weight change, adiponectin was reduced in the groups consuming the low-fat diets relative to the moderate-fat diet (p = 0.008). No effect of the intervention diets or weight loss on CRP, IL-6, or sTNFRI and II was seen in these secondary analyses. CONCLUSIONS: In relatively healthy adults, moderate weight loss had minimal effects on systemic inflammation, and raised plasma adiponectin only modestly. A lower dietary fat and higher carbohydrate content had little impact on measures of systemic inflammation, but reduced adiponectin concentrations compared to a moderate-fat diet. The latter may be of concern given the consistent and strong inverse association of plasma adiponectin with many chronic diseases.

Medical Subject Headings (MeSH)
AdiponectinAdultAgedBiomarkersBody Mass IndexC-Reactive ProteinCaloric RestrictionDiet, Fat-RestrictedDietary CarbohydratesDietary FatsDietary ProteinsEnergy IntakeFemaleHumansInflammationInterleukin-6MaleMiddle AgedReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IIYoung Adult
Study Links
Quality Scores
Safety85
Efficacy60/10
Quality80/10
Citation Metrics
Total Citations14
Citations/Year1.6
Relative Citation Ratio0.57
NIH Percentile31.1%
Research Impact Scores
APT Score0.75
Weight Score1.81
Normalized Score0.74
Related Supplements